UNAUDITED CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current Assets
Cash	$ 104,487,225	$ 89,411,835
Short-term investment	1,347,250	0
Accounts receivable, net of allowance for doubtful accounts	21,539,879	16,757,368
Inventories	69,744,364	71,338,590
Other receivables	1,843,139	2,594,461
Prepayments and prepaid expenses	2,063,454	1,591,696
Deferred tax assets	1,768,319	1,999,563
Total Current Assets	202,793,630	183,693,513
Property, plant and equipment, net	40,438,504	40,546,539
Intangible assets, net	5,109,949	6,520,671
Land use rights, net	5,779,983	5,487,343
Prepayments and deposits for property, plant and equipment	7,856,130	4,287,492
Equity method investment	9,888,236	8,357,017
Total Assets	271,866,432	248,892,575
Current liabilities
Short-term bank loans	0	11,018,000
Accounts payable	3,486,567	4,996,463
Due to related parties	4,597,741	3,319,938
Other payables and accrued expenses	23,364,025	30,661,794
Advance from customers	5,287,022	4,365,523
Advance from customers - a related party	0	486,602
Income tax payable	3,227,566	5,373,633
Other taxes payable	2,280,812	2,189,913
Derivative liabilities - warrants	0	5,410,419
Total Current Liabilities	42,243,733	67,822,285
Other payable	344,804	343,477
Deferred tax liabilities	1,478,650	1,685,772
Total Liabilities	44,067,187	69,851,534
Stockholders' Equity
Common stock: par value $.0001; 100,000,000 shares authorized; 26,538,625 and 25,601,125 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively	2,654	2,560
Additional paid-in capital	58,972,454	48,838,311
Retained earnings	99,716,888	73,920,811
Accumulated other comprehensive income	13,811,804	12,750,682
Total stockholders' equity attributable to China Biologic Products, Inc.	172,503,800	135,512,364
Noncontrolling interest	55,295,445	43,528,677
Total Equity	227,799,245	179,041,041
Commitments and contingencies	0	0
Total Liabilities and Equity	$ 271,866,432	$ 248,892,575